Mhs Pharmaceuticals Private Limited, a amalgamated private limited company, was established on 12 June 2008 in Hyderabad, Telangana, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24233TG2008PTC059624. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹7.01 Cr and a paid-up capital of ₹7.01 Cr.
It upholds a compliant status. Its leadership includes Paidiwar Srinivas (Director), Bhaskar Reddy Cherukupalli (Director). Past directors included Madhukar Reddy Gangadi, Prasad Reddy Battinapatla, Parag Jain. Its latest AGM occurred on 10 July 2024, with the balance sheet filed on 31 March 2024. It is based at H. No: 11-6-56, Survey No: 257 & 258/1, Opp:Idpl Railway Siding Road,(Moosapet),, Kukatpally, Hyderabad, Telangana, 500037.
U24233TG2008PTC059624
059624
12 June 2008
₹7.01 Cr
₹7.01 Cr
Roc Hyderabad
Unlisted
Amalgamated
Explore comprehensive insights into Mhs Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Paidiwar Srinivas | Director | 04 Apr 2011 | Current |
| Bhaskar Reddy Cherukupalli | Director | 12 Jun 2008 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 04 Apr 2011 | Past |
| Pramod Abcsdd | Director | 25 Apr 2024 | Past |
| Pramod Abcsdd | Company Secretary | 15 Sep 2021 | Past |
| Pramod Abcsdd | Additional Director | 14 Sep 2017 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2011 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Mhs Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 87.45% decrease. The company also saw a substantial improvement in profitability, with a 36.92% increase in profit. The company's net worth dipped by a decrease of 0.38%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Mhs Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Mhs Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Mhs Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mhs Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Mhs Pharmaceuticals Private Limited last Annual general meeting of members was held on 10 Jul 2024 as per latest MCA records. was completed.
Progress on Mhs Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was documented.
Paidiwar Srinivas was appointed as a Director was appointed as a Director on 04 Apr 2011 & has been associated with this company since 14 years 8 months . was recorded as a recent event.
Progress on Bhaskar Reddy Cherukupalli was appointed as a Director was appointed as a Director on 12 Jun 2008 & has been associated with this company since 17 years 6 months . was documented.
Progress on Mhs Pharmaceuticals Private Limited was registered on 12 Jun 2008 with Roc Hyderabad & aged 17 years 6 months as per MCA records. was documented.
Medplus, a pharmacy retail chain based in Hyderabad, has decided to abandon its proposed Rs 1200 crore fundraising plan and has halted the expansion of its diagnostic business. The company will focus on expanding its pharmacy business using internal accruals and working capital loans. .
The CIN of Mhs Pharmaceuticals Private Limited is U24233TG2008PTC059624.
Mhs Pharmaceuticals Private Limited is headquartered at H. No: 11-6-56, Survey No: 257 & 258/1, Opp:Idpl Railway Siding Road,(Moosapet),, Kukatpally, Hyderabad, Telangana, 500037.
Mhs Pharmaceuticals Private Limited was incorporated on 12 June 2008.
The current directors of Mhs Pharmaceuticals Private Limited are
The primary industry of Mhs Pharmaceuticals Private Limited is Trade.
Mhs Pharmaceuticals Private Limited is unlisted.
The authorized capital of Mhs Pharmaceuticals Private Limited is ₹7.01 Cr, and the paid-up capital is ₹7.01 Cr.
The compliance status of Mhs Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX